Dr. David Sommerhalder, MD
Claim this profileNEXT Oncology
Expert in Solid Tumors
Expert in Cancer
27 reported clinical trials
35 drugs studied
Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
KRAS positive
2Cancer
Global LeaderStage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials David Sommerhalder, MD is currently running
ZW191
for Advanced Cancers
The purpose of this study is to find out if ZW191 is safe and can treat participants with advanced cancers, including ovarian, endometrial, and non-small cell lung cancers.
Recruiting1 award Phase 13 criteria
GSK5764227
for Advanced Cancer
The goal of this study is to assess the safety, tolerability, clinical activity and pharmacokinetics of GSK5764227. The study will also see how the levels of GSK5764227 will change over time at different dose amounts when administered alone and in combination with other medicines like carboplatin, cisplatin, atezolizumab, pembrolizumab, durvalumab, bevacizumab, cetuximab.
Recruiting1 award Phase 12 criteria
More about David Sommerhalder, MD
Clinical Trial Related3 years of experience running clinical trials · Led 27 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments David Sommerhalder, MD has experience with
- Pembrolizumab
- AMV564
- MPT-0118
- Nab-paclitaxel
- ORIC-101
- BBP-398 (Formerly Known As IACS-15509)
Breakdown of trials David Sommerhalder, MD has run
Solid Tumors
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Sommerhalder, MD specialize in?
David Sommerhalder, MD focuses on Solid Tumors and Cancer. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Stage III.
Is David Sommerhalder, MD currently recruiting for clinical trials?
Yes, David Sommerhalder, MD is currently recruiting for 12 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that David Sommerhalder, MD has studied deeply?
Yes, David Sommerhalder, MD has studied treatments such as Pembrolizumab, AMV564, MPT-0118.
What is the best way to schedule an appointment with David Sommerhalder, MD?
Apply for one of the trials that David Sommerhalder, MD is conducting.
What is the office address of David Sommerhalder, MD?
The office of David Sommerhalder, MD is located at: NEXT Oncology, San Antonio, Texas 78229 United States. This is the address for their practice at the NEXT Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.